GAMCO Investors’s Aratana Therapeutics, Inc. PETX Stock Holding History

GAMCO Investors’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-20,558	Closed	-$106K	–	973
2019 Q2	$106K	Buy	+20,558	New	+$92.4K	﹤0.01%	908

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

GAMCO Investors's PETX Position: Q3 2019 in Review

GAMCO Investors sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 20,558 shares — an estimated $106K sold.

GAMCO Investors first reported a position in PETX in Q2 2019 and held it in 1 quarter. The position peaked at $106K in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

GAMCO Investors reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
GAMCO Investors sold 20,558 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $106K.
GAMCO Investors first reported a position in Aratana Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
GAMCO Investors's Aratana Therapeutics, Inc. position peaked at $106K in Q2 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on GAMCO Investors's 13F filing for Q3 2019, filed 1 Nov 2019.